IRIS
SALVATORE, Giuliana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.967
EU - Europa 4.050
AS - Asia 1.408
SA - Sud America 270
Continente sconosciuto - Info sul continente non disponibili 21
AF - Africa 20
OC - Oceania 4
Totale 12.740
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.929
RU - Federazione Russa 1.554
UA - Ucraina 675
SG - Singapore 530
VN - Vietnam 453
IT - Italia 412
SE - Svezia 345
GB - Regno Unito 304
CN - Cina 299
DE - Germania 291
BR - Brasile 231
FR - Francia 168
FI - Finlandia 92
NL - Olanda 82
HK - Hong Kong 29
PL - Polonia 24
CA - Canada 20
AT - Austria 19
EU - Europa 19
IN - India 18
BE - Belgio 15
AR - Argentina 14
IE - Irlanda 14
CZ - Repubblica Ceca 12
JP - Giappone 11
TR - Turchia 10
MX - Messico 9
ZA - Sudafrica 8
PK - Pakistan 7
EC - Ecuador 6
LV - Lettonia 6
BD - Bangladesh 5
KR - Corea 5
PT - Portogallo 5
SA - Arabia Saudita 5
BG - Bulgaria 4
CO - Colombia 4
ES - Italia 4
IL - Israele 4
IQ - Iraq 4
MA - Marocco 4
PE - Perù 4
PY - Paraguay 4
RO - Romania 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
UY - Uruguay 3
VE - Venezuela 3
AM - Armenia 2
AU - Australia 2
BY - Bielorussia 2
BZ - Belize 2
CH - Svizzera 2
DK - Danimarca 2
EG - Egitto 2
GR - Grecia 2
HU - Ungheria 2
JO - Giordania 2
LK - Sri Lanka 2
MY - Malesia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BT - Bhutan 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
HR - Croazia 1
ID - Indonesia 1
IR - Iran 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LT - Lituania 1
MC - Monaco 1
MK - Macedonia 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 12.740
Salva come PNG Salva come JPEG
Città #
Fairfield 965
Woodbridge 707
Houston 587
Chandler 454
Ann Arbor 444
Ashburn 440
Seattle 395
Dong Ket 377
Wilmington 377
Cambridge 327
Dallas 292
Moscow 272
Nyköping 220
The Dalles 217
Singapore 216
Dearborn 207
Jacksonville 177
Boardman 157
Southend 146
Naples 115
Beijing 102
Napoli 76
Princeton 70
Lawrence 64
Groningen 63
Grafing 59
Yubileyny 58
New York 57
Ogden 52
Munich 43
Shanghai 41
San Diego 36
Los Angeles 35
Ho Chi Minh City 34
Helsinki 33
Hong Kong 28
Düsseldorf 26
Des Moines 24
Formia 23
Milan 23
São Paulo 23
London 19
Jinan 18
Norwalk 17
Lauterbourg 15
Brussels 14
Chicago 14
Hanoi 14
Hefei 14
Rome 14
Kunming 13
Boydton 12
Frankfurt am Main 12
Vienna 12
Auburn Hills 11
Dublin 11
Kraków 11
Tokyo 11
Boston 10
Nanjing 10
Santa Clara 10
Amsterdam 9
Atlanta 9
Redmond 9
Warsaw 9
Afragola 8
Bremen 8
Edinburgh 8
Nocera Inferiore 8
Redwood City 8
Brno 7
Buenos Aires 6
Nanchang 6
Nuremberg 6
Riga 6
Shenyang 6
Stockholm 6
Tampa 6
Turku 6
Casoria 5
Chennai 5
Guangzhou 5
Kilburn 5
Montreal 5
Nocera Superiore 5
Recife 5
Rio de Janeiro 5
St Louis 5
Bexley 4
Charlotte 4
Council Bluffs 4
Curitiba 4
Hangzhou 4
Johannesburg 4
Jundiaí 4
Matawan 4
Portsmouth 4
Salt Lake City 4
Shenzhen 4
Tashkent 4
Totale 8.548
Salva come PNG Salva come JPEG
Nome #
Extracellular superoxide dismutase is a thyroid differentiation marker down-regulated in cancer 330
TWIST1/miR-584/TUSC2 pathway induces resistance to apoptosis in thyroid cancer cells 289
Unveiling the miRNAs responsive to physical activity/exercise training in cancer: A systematic review 269
A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma 264
Junctional adhesion molecule-A is down-regulated in anaplastic thyroid carcinomas and reduces cancer cell aggressiveness by modulating p53 and GSK3 α/β pathways 260
Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer 257
Long-term recreational football training and health in aging 253
Anterior gradient protein 2 promotes survival, migration and invasion of papillary thyroid carcinoma cells 243
Anaplastic Thyroid Carcinoma: Molecular Tools for Diagnosis and Therapy 229
Imaging of thyroid tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. 228
Cytostatic Activity of Adenosine Triphosphate-Competitive Kinase Inhibitors in BRAF Mutant Thyroid Carcinoma Cells 224
RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma 223
Identification of polo-like kinase 1 as a potential therapeutic target in anaplastic thyroid carcinoma 222
BAY 43-9006 inhibition of oncogenic RET mutants. 221
Multimodal imaging for a theranostic approach in a murine model of B-cell lymphoma with engineered nanoparticles 212
A set of miRNAs participates in the cellular senescence program in human diploid fibroblasts. 208
miR-650 promotes motility of anaplastic thyroid cancer cells by targeting PPP2CA 208
Preclinical Imaging for the Study of Mouse Models of Thyroid Cancer 207
The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinoma 205
YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypes 205
Analysis of BRAF Point Mutation and RET/PTC Rearrangement Refines the Fine-Needle Aspiration Diagnosis of Papillary Thyroid Carcinoma 204
Glial cell line-derived neurotrophic factor induces proliferative inhibition of NT2/D1 cells through RET-mediated up-regulation of the cyclin-dependent kinase inhibitor p27(kip1) 201
BRAF Is a Therapeutic Target in Aggressive Thyroid Carcinoma 200
Different mutations of the RET gene cause different human tumoral diseases 198
Identification of targets of twist1 transcription factor in thyroid cancer cells. 198
Receptor tyrosine kinase inhibitors in thyroid cancer 193
BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas 191
High-Frequency Ultrasound-Guided Injection for the Generation of a Novel Orthotopic Mouse Model of Human Thyroid Carcinoma 191
Induction of caspase-dependent programmed cell death in B-cell chronic lymphocytic leukemia by anti-CD22 immunotoxins 190
BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas 189
DNA immunization followed by a single boost with cells: a protein-free immunization protocol for production of monoclonal antibodies against the native form of membrane proteins 182
Glial cell line-derived neutrotrophic factor and neurturin can act as paracrine growth factors stimulating DNA synthesis of Ret-expressing spermatogonia 182
Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma 180
The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells 180
Dissecting the molecular pathways involved in the effects of physical activity on breast cancers cells: A narrative review 180
Generation and characterization of novel monoclonal antibodies to the Ret receptor tyrosine kinase 178
FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma. 172
Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness 171
Only the substitution of methionine 918 with a threonine and not with other residues activates RET transforming potential 171
PATE, a gene expressed in prostate cancer, normal prostate, and testis, identified by a functional genomic approach 166
Tyrosines 1015 and 1062 are in vivo autophosphorylation sites in ret and ret-derived oncoproteins 165
Morphological ultrasound microimaging of thyroid in living mice 165
Identification of a novel subtype of H4-RET rearrangement in a thyroid papillary carcinoma and lymph node metastasis 163
Novel candidate genes of thyroid tumourigenesis identified in Trk-T1 transgenic mice. 162
MRP8, a new member of ABC transporter superfamily, identified by EST database mining and gene prediction program, is highly expressed in breast cancer 159
High Frequency Ultrasound for the development of an Orthotopic mouse model of Human Follicular Thyroid Carcinoma 156
Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas 155
Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease 154
Presence of BRAF V600E in Very Early Stages of Papillary Thyroid Carcinoma 154
TWIST1 plays a pleiotropic role in determining the anaplastic thyroid cancer phenotype 150
Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas 147
Mitogenic effects of the up-regulation of MiniChromosome Maintenance proteins (MCM) in anaplastic thyroid carcinoma 146
Molecular profile of hyalinizing trabecular tumors of the thyroid: high prevalence of RET/PTC rearrangements and absence of B-raf and N-ras point mutations 145
Monitoring training in non-professional soccer players by coupling SSGs and GPS technology: effects of pitch size and players role 145
miR-622 Is a Novel Potential Biomarker of Breast Carcinoma and Impairs Motility of Breast Cancer Cells Through Targeting NUAK1 Kinase 143
Pros and cons of cellular studies in developing new drugs for thyroid cancers 141
Regular football training down-regulates miR-1303 muscle expression in veterans 141
Molecular biology of the MEN2 gene 138
Frequent mutation of PIK3CA in Anaplastic Thyroid Cancer 136
Adiponectin and leptin exert antagonizing effects on proliferation and motility of papillary thyroid cancer cell lines 133
Improved cytotoxic activity toward cell lines and fresh leukemia cells of a mutant anti-CD22 immunotoxin obtained by antibody phage display 129
The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype 126
High prevalence of RET/PTC rearrangements in Ukrainian and Belarussia post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant 118
Effects of Annurca Flesh Apple Polyphenols in Human Thyroid Cancer Cell Lines 117
Evolution of intra-tumoral heterogeneity across different pathological stages in papillary thyroid carcinoma 116
The TUSC2 Tumour Suppressor Inhibits the Malignant Phenotype of Human Thyroid Cancer Cells via SMAC/DIABLO Protein 111
RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes 109
miR-331-5p Affects Motility of Thyroid Cancer Cell Lines and Regulates BID Expression 105
Preclinical Imaging Evaluation of miRNAs' Delivery and Effects in Breast Cancer Mouse Models: A Systematic Review 97
The lncRNA TEX41 is upregulated in pediatric B-Cells Acute Lymphoblastic Leukemia and it is necessary for leukemic cell growth 78
Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype 72
Exercise’s impact on lung cancer molecular mechanisms: a current overview 67
Insight into the Role of the miR-584 Family in Human Cancers 62
Association of radiomic features with genomic signatures in thyroid cancer: a systematic review. 53
Aberrant Expression of Non-Coding RNAs in Pediatric T Acute Lymphoblastic Leukemia and Their Potential Application as Biomarkers 52
Novel Biological Strategies for Melanoma Therapy: A Focus on lncRNAs and Their Targeting 45
Nanogel-Mediated Delivery of Doxorubicin and Curcumin in Thyroid Cancer Cells 41
Totale 12.970
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.214
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.214
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.053 0 0 0 0 0 85 148 51 74 154 50 491
2021/2022783 53 140 26 199 16 24 108 53 71 41 47 5
2022/20231.485 144 91 140 172 229 216 56 161 159 44 55 18
2023/2024390 29 29 34 23 11 48 19 14 79 23 26 55
2024/20252.981 60 230 36 60 34 293 624 987 148 114 306 89
2025/2026988 166 294 212 137 162 17 0 0 0 0 0 0
Totale 12.970